Resistance to treatment for methicillin-resistant Staphylococcus aureus (MRSA)causing nosocomial infection has become a serious medical issue and currently, there is no effective antibiotic against MRSA but vancomycin, teicoplanin and arbekacin. MRSA first emerged in the late 1970s1*, and subsequently, the number ofmethicillinresistant strains have increased, causing severe clinical and management problems in hospitals throughout the world.
Although manystudies have reported that marine algae extracts contain antibacterial activity2~9), these reports were published from 1960 to 1980, when MRSA was relatively rare. The current situation concerning MRSA has promptedre-evaluation of these reports and has aroused newinterest in using marine algae sources for developing novel antibiotics. Therefore, in this study, we first screened a wide variety of Japanese marine algae for the presence of antibacterial activity against 10 different isolates of MRSA. Then we evaluated the potency of MeOH-extracts from algae which tested positive for anti-MRSA activity using a dose-response assay.
Materials and Methods Sample Algae and Extracts A total of 857 algae samples comprising of 308 species (91 brown algae, 154 red algae, 55 green algae and 8 others) were collected and their extracts were prepared as described in our previous paper10). These filtered extracts were concentrated up to 10 fold by freeze-drying what was used in the antibacterial assays. 
Antibacterial Assays
First, MRSAor MSSAstrains were inoculated in 5 ml ofTSB medium (Difco Laboratories Inc.), and incubated by shaking (120rpm) at 36°C for 1 day. After culturing, 20ml of TSB medium containing 0.8% agar was gently mixed with each test culture fluid to give approximately 106CFU/ml and overlayed on a TSA medium (Difco Laboratories Inc.). Antibacterial assays for the other strains, B. subtilis and P. aeruginossa were carried out on a TSA, and V. parahaemolyticus on a Marine agar media (Difco Laboratories Inc.). Sterilized paper disks (i.d. 8 mm, Advantec), which were permeated with 50/d of PBS-or MeOH-extracts and dried completely, were put on the double layer agar media. These plates were incubated at 36°C for 1 day for MRSA, MSSAand the control P. aeruginosa strains. B. subtilis and V. parahaemolyticus were incubated at 25°C for 1 day.
Dose Response of Algal Extracts
The positive algal extracts determined as possessing strong anti-MRSA activity were further examined for assessing the minimumconcentration for antibacterial activity against the 10 clinical isolates of MRSAusing a dose response assay. Approximated minimum concentrations were assessed using paper disks, which were absorbed with crude MeOH-extracts at concentrations ranging from 1.25 to 1000/ig per disk. MRSAsubstances which were finally purified with HPLC were subjected to mass spectrometry and elemental analyses.
Results
A total of 308 marine algae species were first prescreened for antibacterial activity against MSSAand then rescreened against 10 strains of MRSA. Wefound anti-MSSA activity from the MeOH-extracts of 64 species. The incidence of detection was 30.9% in the green algae (17 of 55 species), 27.5% in the brown algae (25 of91 species), and 14.3% in the red algae (22 of 154 species) (Figure 1 ). After rescreening for anti-MRSA activity, we found anti-MRSA activity in many species of marine algae (29.4 % of green, 84% of brown, and 55% of red algae) which showed positive anti-MSSA activity. However, the potency of anti-MRSA activity was variable depend on which strains was tested.
Significant anti-MRSA activity was found more in the brown algae than in the green or red algae. Antibacterial activity was also found against the Gram-negative bacteria, Pseudomonas aeruginosa and Vibrio parahaemolyticus. The MeOH-extracts derived from 6 brown algae, Gelidium elegans, Dictyopteris undulata, Ishige okamurae, Ecklonia kurome, Dictyota spinulosa, and 
Discussion
To the best of our knowledge, this paper is the first report about anti-MRSAactivity in vitro from marine algae located on Japan's coasts. Previously, other reports showed that some distinct seaweeds contain antimicrobial substances against Gram-positive and -negative bacteria3'4'11>12). However, most of the previous papers described antibacterial activity from seaweeds against only one strain of Staphylococcus aureus, and there were no mention of anti-MRSA activity which might have chemotherapeutic value for nosocomial infection.
In the present investigation, we found antibacterial activity in vitro in 38 of 308 marine algae species which were collected from Japan's coasts, and most of these antibacterial activities were not only specific against
MSSAstrains, but also against MRSA strains. Brown algae were found to have the most potential for developing new anti-MRSAagents. Furthermore, this is the first time to detect antimicrobial activity from the substances from one of these algae, Laurencia brongniartii, which might be bromindoles by judging from molecular formula and molecular weight analyses. These bromindole compoundsare knownas someof secondary metabolites in this alga13). However, such an antimicrobial activity described here has never been reported.
Some algae exhibited different antibacterial potency according to location and time of year when the collection was performed (data not shown). It appears that the algae produce different bioactive substances in accordance with the environment and stage of life cycle, or there maybe a difference in the amount of antibacterial substances produced. This seasonal variation in the antibacterial activity of seaweeds has been previously reported14).
Since the availability of soil microorganisms may have reached its limit as resource for antibacterial agents, this paper describes that marine algae, which is a reliable resource, may be candidate for the development of new anti-MRSA agents.
